Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001422996-25-000009

President sold 50,000 shares at an average $20.26 ($1,012,764)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jaen Juan C. · President

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-17 Sale : show line 1 in the form 10b5-1 −37,114 $20.23 $750,720 1,049,946 I
2025-11-17 Sale : show line 2 in the form 10b5-1 −7,836 $20.71 $162,307 1,042,110 I
2025-11-18 Sale : show line 3 in the form 10b5-1 −5,050 $19.75 $99,738 1,037,060 I
Open-market sales · 50,000 sh · avg $20.26 · $1,012,764
Loading xslF345X05/wk-form4_1763588347.xml…